» Articles » PMID: 12673463

Topical Application of Honey in the Management of Radiation Mucositis: a Preliminary Study

Overview
Specialties Critical Care
Oncology
Date 2003 Apr 4
PMID 12673463
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to evaluate the effect of pure natural honey on radiation-induced mucositis.

Patients And Methods: Forty patients diagnosed with head and neck cancer requiring radiation to the oropharyngeal mucosal area were divided in to two groups to receive either radiation alone or radiation plus topical application of pure natural honey. Patients were treated using a 6-MV linear accelerator at a dose rate of 2 Gy per day five times a week up to a dose of 60-70 Gy. In the study arm, patients were advised to take 20 ml of pure honey 15 min before, 15 min after and 6 h post-radiation therapy. Patients were evaluated every week for the development of radiation mucositis using the Radiation Therapy Oncology Group (RTOG) grading system.

Main Results: There was significant reduction in the symptomatic grade 3/4 mucositis among honey-treated patients compared to controls; i.e. 20% versus 75% ( p 0.00058). The compliance of honey-treated group of patients was better than controls. Fifty-five percent of patients treated with topical honey showed no change or a positive gain in body weight compared to 25% in the control arm ( p 0.053), the majority of whom lost weight.

Conclusions: Topical application of natural honey is a simple and cost-effective treatment in radiation mucositis, which warrants further multi-centre randomised trials to validate our finding.

Citing Articles

Side effects of prostate cancer therapies and potential management.

Xiao J, Zhang M, Wu D J Biol Methods. 2024; 11(3):e99010018.

PMID: 39544189 PMC: 11557297. DOI: 10.14440/jbm.2024.0019.


Nutrition Modulation of Cardiotoxicity in Breast Cancer: A Scoping Review.

Stephenson E, Mclaughlin M, Bray J, Saxton J, Vince R Nutrients. 2024; 16(21).

PMID: 39519610 PMC: 11547447. DOI: 10.3390/nu16213777.


Clinical efficacy and applicability of natural products in the treatment and prevention of radiotherapy-induced oral mucositis: A systematic review.

Zhang W, Fan L, Xie Y, Gao T, Zeng J PLoS One. 2024; 19(5):e0303988.

PMID: 38781255 PMC: 11115216. DOI: 10.1371/journal.pone.0303988.


Honey in Alleviating Severe Oral Mucositis Among Head and Neck Cancer Patients Undergoing Radiation Therapy.

Li C, Gau S, Chen C, Kao C, Tsai R, Yang H In Vivo. 2024; 38(3):1397-1404.

PMID: 38688612 PMC: 11059902. DOI: 10.21873/invivo.13581.


Geographical Origin Authentication-A Mandatory Step in the Efficient Involvement of Honey in Medical Treatment.

Magdas T, David M, Hategan A, Filip G, Magdas D Foods. 2024; 13(4).

PMID: 38397509 PMC: 10887874. DOI: 10.3390/foods13040532.


References
1.
Rahn R, Adamietz I, Boettcher H, Schaefer V, Reimer K, Fleischer W . Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology. 1997; 195 Suppl 2:57-61. DOI: 10.1159/000246032. View

2.
Schuchter L, Luginbuhl W, Meropol N . The current status of toxicity protectants in cancer therapy. Semin Oncol. 1992; 19(6):742-51. View

3.
Schonekas K, Wagner W, Prott F . Amifostine--a radioprotector in locally advanced head and neck tumors. Strahlenther Onkol. 1999; 175 Suppl 4:27-9. View

4.
Dorr W, Noack R, Spekl K, Farrell C . Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol. 2001; 77(3):341-7. DOI: 10.1080/09553000010018873. View

5.
Tannehill S, Mehta M . Amifostine and radiation therapy: past, present, and future. Semin Oncol. 1996; 23(4 Suppl 8):69-77. View